In a context of strategic refocus but also with a heavy heart that ANGANY announces the end of activities at the R&D laboratory operated by Angany Innovation SAS in Val-de-Reuil,…
Read More
News
Quebec QC, Canada and Val-de-Reuil, France, February 29th, 2024 – ANGANY inc. presents its new logo and colours. In line with more contemporary graphic trends, this new branding underlines ANGANY’s…
ANGANY inc. announces the completion on schedule of its first clinical trial, one assessing the safety and allergenicity of its First-in-Class biologic, a therapeutic candidate against human allergy to cats….
Scope of scientific reflections expands as ANGANY advances clinical development of First-in-Class biologics ANGANY recently hosted members of its Scientific Advisory Board in beautiful Quebec City. This was the company’s…
Quebec City, Canada and Val de Reuil, France, November 22nd, 2023 – ANGANY inc. announces that it has received a unanimous recommendation from its Safety Review Committee to press ahead with its First-in-Human…
ANGANY expands and redefines its executive team to better manage upcoming development stages. Québec, Canada, November 2nd, 2023 – ANGANY announces the appointment of Christine Guillen, PharmD, as Chief Executive…
The Royal Brompton Hospital, in London, begins Clinical Trial of Angany’s Vaccine Candidate to treat Cat Allergy. Quebec City, Canada, October 3, 2023 – Angany Inc., announces that it has received clearance…
Montréal, QC, July 4, 2023. Louis-Philippe Vézina, CEO of ANGANY, and Réjean Lapointe, principal scientist and head of cancer research at the CHUM Research Centre (CRCHUM), have announced a partnership to…
By Dr Guy Tropper, Executive Vice President, Co-Founder Biologics, a class of medications made of complex proteins have come to widespread use in the past two decades, changing the lives…
There is currently no cure for allergies. Over-the-counter and prescription medications relieve patients of symptoms, but don’t prevent allergy from progressing. The only disease-modifying treatment against allergy is desensitization, a…
